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       August 2014 Newsletter 
University of Massachusetts Center for Clinical and Translational Science 
 
  NEWS: 
 
NCATS Tox21 Data Challenge 2014 
 
The Challenge: 
The 2014 Tox21 (http://www.ncats.nih.gov/research/reengineering/tox21/tox21.html) data challenge is 
designed to help scientists understand the potential of the chemicals and compounds being tested through the 
Toxicology in the 21st Century initiative to disrupt biological pathways in ways that may result in toxic effects. 
 
The goal of the challenge is to “crowdsource” data analysis by independent researchers to reveal how well 
they can predict compounds’ interference in biochemical pathways using only chemical structure data.  The 
computational models produced from the Challenge could become decision-making tools for government 
agencies in determining which environmental chemicals and drugs are of the greatest potential concern to 
human health. 
 
All Challenge winners will receive the opportunity to submit a paper for publication in a special thematic issue 
of Frontiers in Environmental Science and recognition on the NCATS website and via social media. 
 
Key Dates: 
• August 18, 2014 NCATS begins accepting submissions 
• November 14, 2014 Registration and submission deadline 
• January 12, 2015 Winners announced 
 
Full details and to register:  https://tripod.nih.gov/tox21/challenge/ 
 
  DID YOU KNOW? 
 
UMMS Master Clinical Trial Agreements 
 
One way institutions such as UMass Medical School expedite industry sponsored clinical trial startup is through 
use of Master Clinical Trial Agreements.  Master Clinical Trial Agreements (MCTAs) allow the institution, study 
team and sponsor to focus on the budget and feasibility for a particular project without having to spend time re-
negotiating standard contract language. 
 
At UMMS, we currently have MCTAs in place with multiple sponsors and are working with sponsors on an 
ongoing basis to establish new relationships to help study teams bring projects up and bring the research to 
participants faster.  You should let potential sponsors know about existing masters, since it may enhance the 
selection of UMass as a participating site. 
 
A consortium of Clinical and Translational Science Awards (CTSA) institutions, including UMass (through the 
Medical School) have been working on an initiative with select industry partners to establish a central MCTA.  
The goal of the central MCTA is to allow participating institutions and sponsors to:  1) significantly speed study 
startup time by eliminating the need to negotiate agreement terms for each individual project; and 2) establish 
a uniform set of expectations regarding sponsor/site responsibilities.  We will keep you updated about this 
important initiative. 
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Active MCTAs at UMMS include: 
Industry Sponsor Cooperative Groups 
Abbott Vascular Alpha Oncology (PRECOG) 
Amgen BrUOG 
Ardea Biosciences Children's Hospital of Philadelphia (CHOP) 
Bayer NMDP (CIMBTR)* 
C.R. Bard* SC Liver Research Consortium 
Biogen Idec Rapid Start Network/Duke 
Celgene CORE Science Solutions/AMyC/AGICC 
Cook UAB 
Dupont University of Florida 
Gemin X     
Genzyme 
GSK 
ILEX  
Merck Sharp & Dohme 
Millenium 
Novartis* 
Novartis Vaccines and 
Diagnostics 
Novo Nordisk 
Parexel 
Pharmacyclics 
Philips 
Precision Therapeutics 
Sanofi-aventis 
Sepracor 
Serono 
Schafer 
Sunesis 
*New in 2014 
 
Small Business Innovation Research / Small Business Technology Transfer Opportunities 
 
NCATS seeks to increase small business participation in federally supported research and development as 
well as private-sector commercialization of technology developed with federal support.  The Center achieves 
this through the federal government’s Small Business Innovation Research (SBIR) and Small Business 
Technology Transfer (STTR) programs.  NCATS is interested in the development of innovative tools, 
technologies and intervention (drug, device, diagnostic) platforms that would support the creation of novel 
therapeutics or diagnostics, especially for rare and neglected diseases.  The application may address any 
stage of translation, from target validation, through pre-clinical and clinical evaluation and intervention 
implementation and dissemination. 
 
Areas of current activity and interest include: 
• Innovative platforms for identification and prioritization of targets for therapeutic intervention with clear clinical 
impact* 
• Technologies to determine alternative uses for existing therapeutic interventions* 
• Tools and technologies to enable assaying of activities of compounds on currently “non-druggable” targets* 
• Phenotypic assay development, including stem cell technology platforms for human “disease-in-a-dish” 
applications and the evaluation of toxicity* 
• Co-crystallization high-throughput screening techniques* 
• Small molecule and biologics analytical characterization* 
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• Tools and technologies that increase the predictivity or efficiency of medicinal chemistry, biologic or other 
intervention optimization* 
• Accelerate bioengineering approaches to the development and clinical application of biomedical materials, 
devices, therapeutics and/or diagnostics* 
• Protein-protein interaction assays for high throughput screening of rare disease related projects 
• Fluorescence probes to replace antibodies for determination of cellular protein translocation 
• Use of continuous flow manufacturing technology to address therapeutics shortages 
• Small autonomous devices for real-time detection of metabolites involved in metabolic and endocrine disorders 
• Computational or Web-based health research methods including: 
o Platforms for generally applicable and scalable multi-disease registries and natural history studies 
o Clinical trials designs and analyses (e.g., for pragmatic clinical trials) 
o Use of patient data in comparative effectiveness studies and in identifying efficient interventions 
• Tools and technologies that increase the efficiency of human subjects research, including development of 
technologies that facilitate rapid diagnosis and/or clinical trial recruitment and subject tracking, IRB evaluation, 
and/or regulatory processes* 
• Educational tools for clinical and translational research 
• Novel platforms, technologies and tools to enable clinical and translational research, particularly those with 
mechanisms for inclusion of patient reported data* 
• Educational tools or materials for engaging communities to participate in research studies 
• Mechanisms that improve dissemination and implementation of effective health interventions by physicians, 
patients, and public 
• Increased efficiency of clinical research conduct including, but not limited to, regulatory decision support, 
appropriate study site selection, patient eligibility analysis, and recruitment tracking 
• Searchable access to information about researchers and their expertise, including but not limited to their 
publications, published data sets, methods, patents, clinical trials, partnerships, collaborators, and clinical 
specialty/expertise (if applicable)* 
• Tools for meaningful sharing of research data with low barrier for provision and user-friendly access* 
• User-friendly mechanisms for voluntary donation by patients of their clinical data from their electronic medical 
record for research purposes 
• Searchable access to information about research resources, facilities, methods, cells, genetic tests, molecules, 
biologic reagents, animals, assays, technologies with links to their use in published research studies* 
• Other topics within NCATS’ mission will be considered 
 
*Please note that NIH has received approval from the Small Business Administration for the topics listed 
above for budgets greater than $225,000 for Phase I SBIR/STTR awards and greater than $1,500,000 for 
Phase II SBIR/STTR awards for the PHS 2014-2 SBIR and STTR Omnibus grant solicitations (see PA-14-071; 
http://grants.nih.gov/grants/guide/pa-files/PA-14-071.html).  NCATS strongly advises applicants to discuss 
this option with their SBIR program officer prior to submitting any award budget in excess of these amounts. 
 
Applicants also are required to follow the NIH Institute and Center-specific budget guidance found in PHS 
2014-2 SBIR/STTR Program Descriptions a Research Topics for NIH, CDC, FDA and ACF; 
http://grants.nih.gov/grants/funding/sbirsttr1/2014-2_SBIR-STTR-topics.pdf). 
 
 
  EVENTS: 
 
Worcester Department of Public Health, UMass Medical School, Dana-Farber/Harvard Cancer Center, 
UMCCTS Community Engagement and Research Section, UMass Worcester Prevention Research Center, 
Common Pathways, and partners presents: 
 
SOCIAL MEDIA IMPACT FOR HEALTH COMMUNICATION 
 
Thursday, September 11, 2014 
10:00 – 11:30 am 
Worcester Public Health 
Room 109 
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25 Meade Street 
Worcester, MA 01610 
 
How can health and community organizations use social media to not only communicate health information, 
but also produce outcomes and influence behavior? 
 
Join a live webinar to learn about both the potential impact and limitations of social media as a tool for health 
communication.  
 
Two experts will present their research findings on the usage of social media for health organizations: 
 
  Shoba Ramanadhan, ScD, MPH 
 
Shoba is a Research Scientist in the Viswanath Lab at the 
Dana-Farber/Harvard Cancer Center at the Harvard School 
of Public Health.  Her research interests center around 
dissemination and implementation, capacity-building, and 
social networks. 
  Sherry Pagoto, PhD 
 
Sherry is an Associate Professor at the University of 
Massachusetts Medical School.  Her research is focused 
on obesity and cancer prevention, and she initiated a 
movement on Twitter with the hashtag #PlankADay to 
promote fitness and health. 
 
This event is free, but registration is required:  
https://docs.google.com/forms/d/18y0Ui3f8YZyiioVZQe_s6hD3rys2l7SG8V4IvoX79qg/viewform 
 
Questions?  Problems?  Phone: 508-459-9664 Email:  commonpathwaysonline@gmail.com 
 
UMass Center for Clinical and Translational Science 
Community Engagement and Research Symposium 
 
“Building on Partnership Strengths to Improve Health in Communities” 
 
Friday, November 7, 2014 
8:00 am – 5:00 pm 
Albert Sherman Center 
University of MA Medical School 
 
Goal of the Symposium:  To build our shared capacity to address health issues in communities throughout 
Massachusetts by creating opportunities for people to: 
• Meet each other 
• Learn more about each other’s work and interests 
• Make connections and plan for future collaborative work 
 
Audience: Community leaders, faculty and staff from all 5 UMass campuses and other organizations and 
institutions interested in partnered research. 
 
 Call for Breakout Session Proposals – Deadline: September 5, 2014 
 
 Call for Poster Abstracts – Deadline: September 15, 2014 
 
Complete information regarding submitting Breakout Session Proposals and/or Poster Abstracts:  
www.umassmed.edu/ccts/community 
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To Register (free) for the Community Engagement and Research Symposium:  
https://docs.google.com/forms/d/1Wsn4LAefK7-dpAzKkP4l2fkkdYGJL0_-O0vq2-Syuwo/viewform?c=0&w=1 
Deadline to register is October 24, 2014. 
 
Questions?  Please contact Amy Borg by email at communityengagement@umassmed.edu or phone at 508-
856-4685. 
 
~Mark your Calendars~ 
 
UMass Center for Clinical and Translational Science 
Seminar Series 2014-2015 Schedule 
12:00-1:00 pm (lunch served) 
Faculty Conference Room, S1-342 
University of Massachusetts Medical School 
 
2014 
Wednesday, September 24 Nate Hafer, PhD 
Director of Operations, UMCCTS 
UMCCTS 2015 Funding Opportunities 
Thursday, October 30 Hong Yu, PhD 
Professor, Quantitative Health 
Sciences, UMMS 
“TBA” 
Wednesday, November 19   
Wednesday, December 17 Julia Hua Fang, PhD 
Professor, Quantitative Health 
Sciences 
“TBA” 
2015 
Tuesday, January 27   
Wednesday, February 25   
Tuesday, March 24   
Thursday, April 23   
Wednesday, May 27   
 
If you are interested in presenting at one of our upcoming UMCCTS Seminars, please contact, Dr. Nate 
Hafer, Director of Operations, UMCCTS, at nathaniel.hafer@umassmed.edu 
 
Duke Translational Medicine Institute 
2014 Community Engagement Conference 
 
National Conference on Engaging Patients, Families and Communities in all Phases of Translational 
Research to Improve Health 
 
Thursday and Friday, August 21 and 22, 2014 
Bethesda, MD 
 
Registration and complete details at:  https://www.dtmi.duke.edu/ce-workshop 
 
Request for Applications for Innovator Presentations at the 
6th Annual 2014 Partnering for Cures Meeting 
 
November 16-18, 2014 
Grand Hyatt – New York 
http://www.partneringforcures.org/ 
 
Each year, 30 innovative, cross-sector R&D collaborations are awarded 25-minute presentation slots at 
Partnering for Cures Annual Cures Meeting.  This platform, based off of an investor conference model, is 
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designed to help engage potential funders, partners, and/or collaborators in moving their existing initiatives 
forward and/or amplifying the impact of their approach. 
 
Collaborations should be aimed at reducing the time and cost of getting new medical solutions (drugs, devices, 
diagnostics, etc.) from discovery to patients; and should involve partners from two or more of the following 
sectors – NGOs/nonprofit foundations, industry (pharmaceutical, biotechnology, device and diagnostic 
companies), research institutes, universities, government agencies, investors, and private philanthropists.  
Partnerships should be established, not merely proposed, at the time of presentation, and should be able to 
provide evidence of outcomes/progress against their goals. 
 
Aspiring presenters must submit a brief, online application through the Partnering for Cures website 
by August 22, 2014.  http://www.partneringforcures.org/program/innovators/ 
 
  FUNDING OPPORTUNITIES: 
 
UMCCTS Small Conference Grants 
Funding Opportunity 
 
Introduction 
The University of Massachusetts Center for Clinical & Translational Science (UMCCTS) is pleased to announce a funding 
call for Small Conference Grants.  This funding opportunity is designed to leverage the convening capacity of the 
UMCCTS to create new, multidisciplinary teams to address a pressing health need.  For the purpose of this award, a 
conference is defined as a symposium, educational program, seminar, workshop, or any other organized and formal 
meeting. 
 
Purpose 
The UMCCTS supports projects that are inter-campus in orientation and directed toward life sciences projects related to 
clinical and translational research.  This fund serves to spur inter-disciplinary collaboration and strengthen the University’s 
research portfolio in clinical and translational research.  By providing seed funding to outstanding faculty members, this 
fund facilitates the development of faculty-to-faculty networks within the University system, thereby leveraging the 
considerable expertise and resources that exist on the individual campuses.  It is assumed that successful conferences 
will serve as a springboard to attract additional funding from extramural sources. 
 
All UMass faculty (Amherst, Boston, Dartmouth, Lowell, Worcester) with an interest in clinical and translational 
science may apply.  Project awards of up to $1,000 can be requested. 
 
Proposals will be accepted on a “rolling basis” (no due date).  Investigators will be notified of award 
approximately 2-3 weeks post submission. 
 
Complete details, criteria to apply, and the application process are available at the UMCCTS website:  
http://www.umassmed.edu/ccts/research/grantopps.aspx 
 
Indiana Clinical and Translational Science Institute 
Indianapolis-based Women’s Fund of Central Indiana 
NEXT Initiative 
 
The Indianapolis-based Women’s Fund of Central Indiana is seeking applicants for the NEXT Initiative to 
support the development and implementation of comprehensive solutions helping women ages 18 to 24 
achieve economic stability. 
 
Invited entrepreneurs will spend the first one to two years incubating a solution that the Women's Fund will 
launch and fund for the subsequent eight to nine years.  It is the intention of this initiative to select two to three 
entrepreneurs who will each receive a salary of $90,000 and full benefits, during the incubation phase, as an 
employee of the Central Indiana Community Foundation. (The Women's Fund is a special-interest fund of 
CICF.) 
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The NEXT Initiative aims to address the gap in culturally appropriate services for vulnerable women in this age 
group -- women who have been mired in economic insecurity and are seeking a path to economic stability. 
 
Letters of intent are due: Tuesday, September 2, 2014.   
 
For more information on the NEXT Initiative, visit http://womensfund.org/next 
 
 
Please remember to cite the CTSA Grant # UL1TR000161 in all supported journal publications. 
 
Visit our website for all the latest news, funding announcements, seminars, educational training, sign-
up for membership, etc., http://www.umassmed.edu/ccts 
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